Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Transcript
What special concerns do pregnant women have with hypertension? What signs should they look for if they have not experienced hypertension in the past?
One of the focuses of that particular paper in [the Journal of American College of Cardiology] JACC was hypertension across a woman's life cycle. The reason that this is important— in particular in pregnancy– [is that] there are several different issues that women need to think about. One is if a woman has pre-existing hypertension going into pregnancy, that's one issue and the hypertension has to be well controlled during the pregnancy.
But, an even bigger concern often is a woman who develops hypertension during pregnancy and/or preeclampsia. [This is] because what we know is that any level of hypertension during pregnancy, or the preeclamptic state, predicts for women a higher risk going forward of developing cardiovascular disease later on in her life.
In addition to the obstetric clinicians as well as internal medicine, family medicine, and even cardiologists who a woman might see, she really needs to be aware of her own blood pressure and to be asking those questions during the monitoring of her pregnancy as to "What is my blood pressure, do I have signs of preeclampsia, are there conditions that I need to worry about?"
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Measurable Residual Disease in Decision-Making: An Opportunity, but Not a Promise
June 13th 2025Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in the European context, but panelists explained the next steps that are required to advance the use of MRD.
Read More
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
June 12th 2025Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.
Read More